Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trialsMattía Galli, Dominick J. Angiolillo, Stefano Benenati et al.|European Heart Journal|2021Cited by 150
Microvascular Dysfunction in Heart Failure With Preserved Ejection FractionDomenico D’Amario, Filippo Crea, Stefano Migliaro et al.|Frontiers in Physiology|2019Cited by 130
Electrical and autonomic cardiac function in patients with Dravet syndromeAngelica Bibiana Delogu, Filippo Crea, Antonella Spinelli et al.|Epilepsia|2011Cited by 94
COX-1 sensitivity and thromboxane A2 production in type 1 and type 2 diabetic patients under chronic aspirin treatmentFabio M. Pulcinelli, Filippo Crea, Luigi M. Biasucci et al.|European Heart Journal|2009Cited by 87
Plasma levels of thromboxane A2 on admission are associated with no-reflow after primary percutaneous coronary interventionGiampaolo Niccoli, Filippo Crea, Simona Giubilato et al.|European Heart Journal|2008Cited by 72